![](/img/cover-not-exists.png)
Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer
Qing Dong, Douglas R. Dougan, Xianchang Gong, Petro Halkowycz, Bohan Jin, Toufike Kanouni, Shawn M. O’Connell, Nicholas Scorah, Lihong Shi, Michael B. Wallace, Feng ZhouVolume:
21
Year:
2011
Language:
english
Pages:
5
DOI:
10.1016/j.bmcl.2011.01.071
File:
PDF, 772 KB
english, 2011